Dehai Wu

机构：Harbin Medical University, Second Affiliated Hospital of Harbin Medical University

发表论文 23 篇 · 总被引 563 次 · h-index 12

代表论文

• A PLCB1–PI3K–AKT Signaling Axis Activates EMT to Promote Cholangiocarcinoma Progression (2021 · Cancer Research · 被引 107)
• Transcriptional Induction of Periostin by a Sulfatase 2–TGFβ1–SMAD Signaling Axis Mediates Tumor Angiogenesis in Hepatocellular Carcinoma (2016 · Cancer Research · 被引 78)
• miR-124 Suppresses Pancreatic Ductal Adenocarcinoma Growth by Regulating Monocarboxylate Transporter 1-Mediated Cancer Lactate Metabolism (2018 · Cellular Physiology and Biochemistry · 被引 57)
• ABCA8 is regulated by miR-374b-5p and inhibits proliferation and metastasis of hepatocellular carcinoma through the ERK/ZEB1 pathway (2020 · Journal of Experimental & Clinical Cancer Research · 被引 54)
• Preclinical In Vitro and In Vivo Evidence of an Antitumor Effect of CX-4945, a Casein Kinase II Inhibitor, in Cholangiocarcinoma (2018 · Translational Oncology · 被引 41)
• A Novel Oxoglutarate Dehydrogenase-Like Mediated miR-214/TWIST1 Negative Feedback Loop Inhibits Pancreatic Cancer Growth and Metastasis (2019 · Clinical Cancer Research · 被引 31)